Impact of Late Treatment-Related Toxicity on Quality of Life Among Patients With Head and Neck Cancer Treated With RadiotherapyJohannes A. Langendijk, Ben J. Slotman, Patricia Doornaert et al.|Journal of Clinical Oncology|2008Cited by 687
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinomaAnne W.M. Lee, Joseph Wee, Wai Tong Ng et al.|Radiotherapy and Oncology|2017Cited by 374
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus StatementDavid Thomson, Sue S. Yom, Adam S. Garden et al.|International Journal of Radiation Oncology*Biology*Physics|2020Cited by 211
European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision makingNicolaus Andratschke, Carsten Nieder, Jonas Willmann et al.|The Lancet Oncology|2022Cited by 192
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal CarcinomaAnne W.M. Lee, Joseph Wee, Wai Tong Ng et al.|International Journal of Radiation Oncology*Biology*Physics|2019Cited by 183